Alliance Wealth Advisors LLC UT Has $261,000 Stock Holdings in CVS Health Co. (NYSE:CVS)

Alliance Wealth Advisors LLC UT lowered its position in CVS Health Co. (NYSE:CVS) by 12.9% during the fourth quarter, HoldingsChannel.com reports. The firm owned 3,309 shares of the pharmacy operator’s stock after selling 491 shares during the quarter. Alliance Wealth Advisors LLC UT’s holdings in CVS Health were worth $261,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. raised its position in CVS Health by 0.4% during the third quarter. Vanguard Group Inc. now owns 117,162,626 shares of the pharmacy operator’s stock valued at $8,180,295,000 after acquiring an additional 485,744 shares in the last quarter. FMR LLC lifted its stake in shares of CVS Health by 29.1% in the 3rd quarter. FMR LLC now owns 27,487,238 shares of the pharmacy operator’s stock valued at $1,919,159,000 after purchasing an additional 6,194,441 shares during the last quarter. Northern Trust Corp boosted its holdings in CVS Health by 2.2% in the third quarter. Northern Trust Corp now owns 14,214,296 shares of the pharmacy operator’s stock worth $992,442,000 after purchasing an additional 305,564 shares in the last quarter. Royal Bank of Canada increased its position in CVS Health by 2.2% during the third quarter. Royal Bank of Canada now owns 14,136,920 shares of the pharmacy operator’s stock worth $987,041,000 after buying an additional 303,512 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in CVS Health by 2.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 12,717,825 shares of the pharmacy operator’s stock valued at $864,821,000 after buying an additional 324,391 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on CVS. Leerink Partnrs reaffirmed an “outperform” rating on shares of CVS Health in a research report on Monday, February 26th. Wells Fargo & Company lowered their price target on CVS Health from $83.00 to $76.00 and set an “equal weight” rating on the stock in a research report on Monday, April 8th. Cantor Fitzgerald reissued an “overweight” rating and set a $87.00 price objective on shares of CVS Health in a research report on Wednesday, April 10th. SVB Leerink initiated coverage on CVS Health in a report on Monday, February 26th. They issued an “outperform” rating and a $88.00 target price on the stock. Finally, StockNews.com lowered CVS Health from a “buy” rating to a “hold” rating in a report on Thursday, February 15th. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $89.44.

CVS Health Price Performance

NYSE CVS traded down $0.15 during trading on Friday, reaching $67.18. 6,396,438 shares of the company traded hands, compared to its average volume of 8,376,818. The company has a market cap of $84.68 billion, a price-to-earnings ratio of 10.40, a P/E/G ratio of 0.89 and a beta of 0.52. The stock’s 50 day moving average price is $74.42 and its two-hundred day moving average price is $73.66. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.86. CVS Health Co. has a 1-year low of $64.41 and a 1-year high of $83.25.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.01 by $0.11. The company had revenue of $93.81 billion during the quarter, compared to analyst estimates of $90.58 billion. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The firm’s revenue was up 11.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.99 EPS. As a group, analysts anticipate that CVS Health Co. will post 8.31 EPS for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.96%. The ex-dividend date of this dividend is Friday, April 19th. CVS Health’s dividend payout ratio is currently 41.18%.

Insider Activity

In related news, EVP Prem S. Shah sold 29,473 shares of the stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the completion of the sale, the executive vice president now directly owns 39,765 shares of the company’s stock, valued at approximately $3,059,916.75. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.24% of the stock is currently owned by company insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.